article thumbnail

UK MHRA publishes guidance on medicines containing valproate

Pharmaceutical Technology

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published updated guidance on valproate-containing medicines.

article thumbnail

Attorney Tope Leyimu Discusses Proposed FDA ban on Hair Relaxer Products Containing Harmful Chemicals – Xtalks Life Science Podcast Ep. 137

XTalks

This episode features an interview with Attorney Temitope (Tope) Leyimu, a toxic exposure attorney at Motley Rice who is leading a lawsuit over hair relaxing products that contain harmful chemicals. The FDA recently issued a recommendation for the recall of chemical hair relaxers containing harmful chemicals. Temitope (Tope) O.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Children’s products labeled water- or stain-resistant may contain PFAS, study says

Scienmag

Seems like kids are always getting into something, so products marketed toward them often claim to repel liquids. Some items contain potentially harmful per- and polyfluoroalkyl substances (PFAS) to accomplish this feat, but companies aren’t required to disclose these “forever chemicals” on labels.

article thumbnail

Some Talc Products Contain Asbestos: Study

The Pharma Data

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. She noted that EWG’s online database has identified more than 2,000 personal care products that contain talc, including more than 1,000 loose or pressed powders that could pose an inhalation risk. MONDAY, Nov.

article thumbnail

Streamlining development with containment in early drug discovery

Drug Discovery World

It may seem counterintuitive to spend time and money on planning for containment and delivery systems for a drug in the earliest stages of discovery when the chances of that molecule making it to market are still quite low. The increasing complexity of drug products has raised concern among pharmaceutical developers. Never too early.

article thumbnail

Container Closure Integrity Testing: A Necessity for Pharmaceutical Industry

Roots Analysis

Considering patient’s health and safety, the drug products are expected to be free from microbial contamination and should be safe for use throughout the drug’s life cycle. Therefore, several quality checks are performed to ensure product’s sterility and stability. Evolving Landscape of Container Closure Integrity Testing Services.

article thumbnail

Early decisions to de-risk the transition to combination products

Bio Pharma Dive

Speeding up the drug development process through a less optimized containment and delivery system may have been an option in the past, but both expectations and the competitive environment are changing.